ScholarIQanswers from OpenAlex

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib

PaperCitations, authors & open-access status

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib have?

ScholarIQcitation count

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has 96 citations in the OpenAlex counts ScholarIQ stores.

When was Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib published?

ScholarIQyear

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has 2013 year in the ScholarIQ index.

What is the open-access status of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

ScholarIQoa status

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has hybrid oa status in the ScholarIQ index.

What is the DOI of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

ScholarIQdoi

The DOI for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

What is the PMID of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

ScholarIQpmid

The PMID for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

What is the OpenAlex record for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

ScholarIQopenalex

The OpenAlex for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial